These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1877448)

  • 1. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator.
    Huang SK; Tan de Guzman WL; Chenarides JG; Okike NO; Vander Salm TJ
    Am Heart J; 1991 Sep; 122(3 Pt 1):720-7. PubMed ID: 1877448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator.
    Guarnieri T; Levine JH; Veltri EP; Griffith LS; Watkins L; Juanteguy J; Mower MM; Mirowski M
    Am J Cardiol; 1987 Nov; 60(13):1061-4. PubMed ID: 3673907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late results of the left subcostal approach for automatic implantable cardioverter defibrillator implantation.
    O'Neill PG; Lawrie GM; Kaushik RR; Harvill LF; Pacifico A
    Am J Cardiol; 1991 Feb; 67(5):387-90. PubMed ID: 1994663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator.
    Manolis AS; Tan-DeGuzman W; Lee MA; Rastegar H; Haffajee CI; Huang SK; Estes NA
    Am Heart J; 1989 Sep; 118(3):445-50. PubMed ID: 2773768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term community hospital experience with the internal defibrillator.
    Porterfield JG; Porterfield LM; Bray L
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):263-6. PubMed ID: 1706835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation.
    Khastgir T; Lattuca J; Aarons D; Murphy J; O'Mara V; Juanteguy J; Veltri EP
    Pacing Clin Electrophysiol; 1991 May; 14(5 Pt 1):768-72. PubMed ID: 1712951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustained ventricular tachycardia/fibrillation.
    Kou WH; Kirsh MM; Bolling SF; Stirling M; Kadish AH; De Buitleir M; Calkins H; Lewis RR; Morady F
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1586-92. PubMed ID: 1721147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antiarrhythmic drugs on epicardial defibrillation energy requirements and the rate of defibrillator discharges.
    Jung W; Manz M; Pfeiffer D; Tebbenjohanns J; Pizzulli L; Lüderitz B
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):198-201. PubMed ID: 7681571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
    Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF
    J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome with the automatic implantable cardioverter-defibrillator.
    Winkle RA; Mead RH; Ruder MA; Gaudiani VA; Smith NA; Buch WS; Schmidt P; Shipman T
    J Am Coll Cardiol; 1989 May; 13(6):1353-61. PubMed ID: 2703616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with the automatic implantable cardioverter defibrillator in sudden death survivors.
    Paull DL; Fellows CL; Guyton SW; Anderson RP
    Am J Surg; 1989 May; 157(5):516-8. PubMed ID: 2712211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The implantable automatic cardioverter-defibrillator].
    Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
    Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with a second-generation cardioverter-defibrillator].
    Meyer BJ; Candinas R; Gloor HO; Bertel O; Amann FW; Turina MI
    Schweiz Med Wochenschr; 1991 Nov; 121(46):1701-5. PubMed ID: 1957143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of high initial epicardial patch defibrillation thresholds following chronic implantation.
    Grubb BP; Mancini M; Temesy-Armos P; Hahn H; Elliott L
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 1):149-51. PubMed ID: 1706497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.
    Marchlinski FE; Flores BT; Buxton AE; Hargrove WC; Addonizio VP; Stephenson LW; Harken AH; Doherty JU; Grogan EW; Josephson ME
    Ann Intern Med; 1986 Apr; 104(4):481-8. PubMed ID: 3954276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The automatic implantable cardioverter-defibrillator. Long-term clinical experience and outcome at a hospital without an open-heart surgery program.
    Cohen TJ; Reid PR; Mower MM; Mirowski M; Aarons D; Juanteguy J; Veltri EP
    Arch Intern Med; 1992 Jan; 152(1):65-9. PubMed ID: 1728931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.